High Throughput Advantage OrangeQS targets industrial-scale high-throughput quantum chip testing, tackling the key bottleneck in moving from lab to production. This presents a clear sales opportunity to quantum chip fabs, contract manufacturers, and research labs aiming to speed up characterization and yield. The offering combines diagnostics protocols, control hardware, and a cryogenic environment to deliver fast, reliable testing.

Flexible Platform The FLEX product configurator and MAX Partnership Program signal a modular, partner-friendly go-to-market. This enables quick quotes and co-developed solutions tailored to different qubit technologies and testing workflows. Ideal entry points for sales teams include pilots that prove configurable test suites against specific chip architectures.

Credibility Build Spin-off status from TNO and QuTech along with a strategic board appointment and ongoing investor interest bolster credibility with potential customers and grant programs. This backdrop is advantageous for pursuing pilots with academic labs and funded research initiatives, and for forming co-funded development partnerships. It also supports credibility in regional government and innovation programs.

Growth Partnerships Active participation in industry events and the launch of a partnership program point to an ecosystem-led growth strategy. Opportunity for channel partnerships with system integrators, research centers, and fab partners to accelerate adoption through joint demonstrations and bundled solutions. Use these partnerships to reach early adopters and scale across multiple regions.

Early Market Traction Current revenue is in the early stage, indicating a need for customer wins and pilots to demonstrate value. The combination of a compelling value proposition for faster chip development and a modular platform suggests strong upside once pilots convert to contracts. Prioritizing target segments such as research labs and early-stage fabs and offering flexible configurations can speed time to first sale.